Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer.

Trial Profile

Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
  • Indications Advanced breast cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms NeoSAMBA
  • Most Recent Events

    • 01 Sep 2016 Planned End Date changed from 1 Jun 2014 to 1 Dec 2016.
    • 01 Sep 2016 Planned primary completion date changed from 1 Dec 2013 to 1 Sep 2016.
    • 18 Mar 2013 Planned end date changed from 1 Feb 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top